Existing approaches to detect and characterize changes during development of monoclonal antibodies (mAbs), next-generation therapeutics, and gene therapies are challenged to deliver the detailed ...
Instrument ushers in a new phase of biologic characterization, empowering scientists to analyze more samples and molecules to meet next-gen drug development challenges FRAMINGHAM, Mass.--(BUSINESS ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する